BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20506129)

  • 1. Purification of cell culture-derived modified vaccinia ankara virus by pseudo-affinity membrane adsorbers and hydrophobic interaction chromatography.
    Wolff MW; Siewert C; Hansen SP; Faber R; Reichl U
    Biotechnol Bioeng; 2010 Oct; 107(2):312-20. PubMed ID: 20506129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capturing of cell culture-derived modified Vaccinia Ankara virus by ion exchange and pseudo-affinity membrane adsorbers.
    Wolff MW; Siewert C; Lehmann S; Hansen SP; Djurup R; Faber R; Reichl U
    Biotechnol Bioeng; 2010 Mar; 105(4):761-9. PubMed ID: 19891005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfated membrane adsorbers for economic pseudo-affinity capture of influenza virus particles.
    Opitz L; Lehmann S; Reichl U; Wolff MW
    Biotechnol Bioeng; 2009 Aug; 103(6):1144-54. PubMed ID: 19449393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of cell culture-derived influenza virus A/Puerto Rico/8/34 by membrane-based immobilized metal affinity chromatography.
    Opitz L; Hohlweg J; Reichl U; Wolff MW
    J Virol Methods; 2009 Nov; 161(2):312-6. PubMed ID: 19591872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of standard and new generation hydrophobic interaction chromatography resins in the monoclonal antibody purification process.
    Chen J; Tetrault J; Ley A
    J Chromatogr A; 2008 Jan; 1177(2):272-81. PubMed ID: 17709111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a polishing step using a hydrophobic interaction membrane adsorber with a PER.C6-derived recombinant antibody.
    Kuczewski M; Fraud N; Faber R; Zarbis-Papastoitsis G
    Biotechnol Bioeng; 2010 Feb; 105(2):296-305. PubMed ID: 19739096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A membrane-based purification process for cell culture-derived influenza A virus.
    Weigel T; Solomaier T; Wehmeyer S; Peuker A; Wolff MW; Reichl U
    J Biotechnol; 2016 Feb; 220():12-20. PubMed ID: 26712479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrophobic-interaction chromatography for purification of influenza A and B virus.
    Weigel T; Soliman R; Wolff MW; Reichl U
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jun; 1117():103-117. PubMed ID: 31005703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theory and use of hydrophobic interaction chromatography in protein purification applications.
    McCue JT
    Methods Enzymol; 2009; 463():405-14. PubMed ID: 19892185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrophobic interaction chromatography: harnessing multivalent protein-surface interactions for purification procedures.
    Jennissen HP
    Methods Mol Biol; 2005; 305():81-99. PubMed ID: 15943009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lectin-affinity chromatography for downstream processing of MDCK cell culture derived human influenza A viruses.
    Opitz L; Salaklang J; Büttner H; Reichl U; Wolff MW
    Vaccine; 2007 Jan; 25(5):939-47. PubMed ID: 17011087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of adsorbents selection on capture efficiency of cell culture derived human influenza viruses.
    Opitz L; Lehmann S; Zimmermann A; Reichl U; Wolff MW
    J Biotechnol; 2007 Sep; 131(3):309-17. PubMed ID: 17765993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel purification strategy for retrovirus gene therapy vectors using heparin affinity chromatography.
    Segura MM; Kamen A; Trudel P; Garnier A
    Biotechnol Bioeng; 2005 May; 90(4):391-404. PubMed ID: 15812800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of an Fc-fusion biologic: clearance of multiple product related impurities by hydrophobic interaction chromatography.
    Evans DR; Macniven RP; Labanca M; Walker J; Notarnicola SM
    J Chromatogr A; 2008 Jan; 1177(2):265-71. PubMed ID: 17692855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic control of protein conformation transition in chromatographic separation based on hydrophobic interactions: molecular dynamics simulation.
    Zhang L; Lu D; Liu Z
    J Chromatogr A; 2009 Mar; 1216(12):2483-90. PubMed ID: 19178912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of native proteins of Escherichia coli BL-21 that display affinity towards Immobilized Metal Affinity Chromatography and Hydrophobic Interaction Chromatography Matrices.
    Tiwari N; Woods L; Haley R; Kight A; Goforth R; Clark K; Ataai M; Henry R; Beitle R
    Protein Expr Purif; 2010 Apr; 70(2):191-5. PubMed ID: 19887109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paper-PEG-based membranes for hydrophobic interaction chromatography: purification of monoclonal antibody.
    Yu D; Chen X; Pelton R; Ghosh R
    Biotechnol Bioeng; 2008 Apr; 99(6):1434-42. PubMed ID: 17972326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current insights on protein behaviour in hydrophobic interaction chromatography.
    Lienqueo ME; Mahn A; Salgado JC; Asenjo JA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):53-68. PubMed ID: 17141587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of fibrinogen with n-alkylagaroses and its purification by critical hydrophobicity hydrophobic interaction chromatograpy.
    Jennissen HP; Demiroglou A
    J Chromatogr A; 2006 Mar; 1109(2):197-213. PubMed ID: 16488424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of membrane adsorber (MA) based purification schemes for the down-stream processing of recombinant h-AT III.
    Reif OW; Freitag R
    Bioseparation; 1994 Dec; 4(6):369-81. PubMed ID: 7765681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.